Imagene AI

Operates the OI Suite platform, a transformative software enterprise solution for AI in translational research, drug discovery, and development.

VisitClaim or join

Founded: 2020
Headquarters: Not disclosed
Company size: Not disclosed
Products tracked: 1

Products by Imagene AI

1 product

OI SuiteA SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data.0.00 reviewsDrug Discovery & Biotech

Pricing for Imagene AI

Subscription

This is the broad commercial model reported for Imagene AI. Product-level terms are listed below when available.

OI SuiteA SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data.

Pricing model: Subscription
Entry option: Free plan

Trust profile

Security and compliance

No compliance claims have been published for this company.

Latest updates from Imagene AI

Jul 162026

Partnership

Imagene AI and Tel Aviv Sourasky University Medical Center Establish Clinical AI Infrastructure

Imagene AI and Tel Aviv Sourasky University Medical Center have established a strategic partnership to develop a clinical AI infrastructure for digital pathology and precision oncology. Utilizing the medical center's I-NEXT research facility, the collaboration aims to validate AI technologies in real-world clinical settings. The initiative focuses on transforming pathology and clinical data into actionable insights to support biomarker-driven clinical trials and personalized cancer treatment. This infrastructure is intended to serve as a platform for biopharma organizations to facilitate research and development programs.

PartnerTel Aviv Sourasky University Medical Center